Industry News
Biotechnology Industry News
Amgen celebrates 25 years of deCODE Genetics as partnership evolves from discovery to development
Amgen celebrates 25 years of deCODE Genetics as partnership evolves from discovery to development mbayer Thu, 05/19/2022 - 08:48
Enanta sinks to multiyear low as phase 2b RSV trial flames out
Enanta sinks to multiyear low as phase 2b RSV trial flames out ntaylor Thu, 05/19/2022 - 06:45
Nanobiotix scales down R&D plan, freezes hiring to close gap between cash runway and phase 3 data
Nanobiotix scales down R&D plan, freezes hiring to close gap between cash runway and phase 3 data ntaylor Thu, 05/19/2022 - 05:52
Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce
Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce mbayer Wed, 05/18/2022 - 15:26
J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3
J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3 gmasson Wed, 05/18/2022 - 15:08
Applied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity paused
Applied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity paused gmasson Wed, 05/18/2022 - 11:11
‘We just don’t have the studies’: New report details critical diversity shortcomings in US clinical research
'We just don’t have the studies': New report details critical diversity shortcomings in US clinical research aarmstrong Wed, 05/18/2022 - 10:08
Flagship Pioneering unfurls cell signaling company Sonata Therapeutics
Flagship Pioneering unfurls cell signaling company Sonata Therapeutics jwaldron Wed, 05/18/2022 - 09:39
Barber buzzes into Aquestive CEO post as Kendall leaves amid FDA delay
Barber buzzes into Aquestive CEO post as Kendall leaves amid FDA delay ntaylor Wed, 05/18/2022 - 08:36
With lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B
With lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B ntaylor Wed, 05/18/2022 - 07:30
Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events
Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events aarmstrong Tue, 05/17/2022 - 15:06
UPDATE: Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events
UPDATE: Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events aarmstrong Tue, 05/17/2022 - 15:06
FDA has change of heart, plans to convene advisory meeting for Cytokinetics’ cardiac med
FDA has change of heart, plans to convene advisory meeting for Cytokinetics' cardiac med mbayer Tue, 05/17/2022 - 10:35
Ampio’s years of troubles come to a head with internal investigation, trio of COVID trial failures
Ampio's years of troubles come to a head with internal investigation, trio of COVID trial failures aarmstrong Tue, 05/17/2022 - 09:18
Scholar Rock in a hard place as biotech lays off 25% of staff, narrows pipeline and loses CMO
Scholar Rock in a hard place as biotech lays off 25% of staff, narrows pipeline and loses CMO jwaldron Tue, 05/17/2022 - 09:15
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center ntaylor Tue, 05/17/2022 - 07:34
AstraZeneca bags pan-variant COVID-19 antibodies from stealthy biotech in $157M deal
AstraZeneca bags pan-variant COVID-19 antibodies from stealthy biotech in $157M deal ntaylor Tue, 05/17/2022 - 06:06
Remix closes $70M funding with pipeline ‘really humming,’ but to what tune?
Remix closes $70M funding with pipeline 'really humming,' but to what tune? mbayer Mon, 05/16/2022 - 16:24
After 14 years, Agios is looking for a partner to tango with, but tough changes lie ahead
After 14 years, Agios is looking for a partner to tango with, but tough changes lie ahead aarmstrong Mon, 05/16/2022 - 15:49
VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions
VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions gmasson Mon, 05/16/2022 - 10:39